These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

778 related items for PubMed ID: 19240241

  • 1. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
    Klatte T, Seligson DB, LaRochelle J, Shuch B, Said JW, Riggs SB, Zomorodian N, Kabbinavar FF, Pantuck AJ, Belldegrun AS.
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
    [Abstract] [Full Text] [Related]

  • 2. Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma.
    Klatte T, Remzi M, Zigeuner RE, Mannweiler S, Said JW, Kabbinavar FF, Haitel A, Waldert M, de Martino M, Marberger M, Belldegrun AS, Pantuck AJ.
    J Urol; 2010 Jul; 184(1):53-8. PubMed ID: 20478577
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
    Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS.
    Clin Cancer Res; 2007 Dec 15; 13(24):7388-93. PubMed ID: 18094421
    [Abstract] [Full Text] [Related]

  • 4. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K, Mizuno R, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Nakashima J, Oya M.
    J Urol; 2009 Feb 15; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [Abstract] [Full Text] [Related]

  • 5. p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma.
    Shvarts O, Seligson D, Lam J, Shi T, Horvath S, Figlin R, Belldegrun A, Pantuck AJ.
    J Urol; 2005 Mar 15; 173(3):725-8. PubMed ID: 15711252
    [Abstract] [Full Text] [Related]

  • 6. Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.
    Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Belldegrun AS, Horvath S, Figlin RA.
    J Urol; 2005 May 15; 173(5):1496-501. PubMed ID: 15821467
    [Abstract] [Full Text] [Related]

  • 7. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC, Zincke H, Lohse CM, Sebo TJ, Riehle D, Weaver AL, Blute ML.
    Cancer; 2002 Apr 15; 94(8):2180-4. PubMed ID: 12001115
    [Abstract] [Full Text] [Related]

  • 8. Using protein expressions to predict survival in clear cell renal carcinoma.
    Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Figlin RA, Horvath S, Belldegrun AS.
    Clin Cancer Res; 2004 Aug 15; 10(16):5464-71. PubMed ID: 15328185
    [Abstract] [Full Text] [Related]

  • 9. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L, Patard JJ, Chiodini P, Schips L, Ficarra V, Tostain J, de La Taille A, Altieri V, Lobel B, Zigeuner RE, Artibani W, Guillé F, Abbou CC, Salzano L, Gallo C.
    Cancer; 2005 Oct 01; 104(7):1362-71. PubMed ID: 16116599
    [Abstract] [Full Text] [Related]

  • 10. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.
    Minervini A, Di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, Salinitri G, Rocca CD, Lapini A, Nesi G, Bevilacqua G, Minervini R, Carini M.
    J Urol; 2008 Oct 01; 180(4):1284-9. PubMed ID: 18707725
    [Abstract] [Full Text] [Related]

  • 11. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
    Liu Z, Lv J, Ding K, Fu Q, Cao Q, Wang F.
    Int J Urol; 2009 Mar 01; 16(3):268-73. PubMed ID: 19087209
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
    Phuoc NB, Ehara H, Gotoh T, Nakano M, Yokoi S, Deguchi T, Hirose Y.
    Urology; 2007 May 01; 69(5):843-8. PubMed ID: 17482919
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, Bui MH, Liu X, Horvath S, Figlin RA, Belldegrun AS.
    Cancer; 2005 Jun 15; 103(12):2517-25. PubMed ID: 15880379
    [Abstract] [Full Text] [Related]

  • 14. Impact of clinical variables on predicting disease-free survival of patients with surgically resected renal cell carcinoma.
    Brookman-Amissah S, Kendel F, Spivak I, Pflanz S, Roigas J, Klotz T, May M.
    BJU Int; 2009 May 15; 103(10):1375-80. PubMed ID: 19040527
    [Abstract] [Full Text] [Related]

  • 15. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
    Iimura Y, Saito K, Fujii Y, Kumagai J, Kawakami S, Komai Y, Yonese J, Fukui I, Kihara K.
    J Urol; 2009 Mar 15; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
    [Abstract] [Full Text] [Related]

  • 16. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
    Fujii Y, Saito K, Iimura Y, Sakai Y, Koga F, Kawakami S, Kumagai J, Kihara K.
    J Urol; 2008 Oct 15; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
    [Abstract] [Full Text] [Related]

  • 17. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
    Lam JS, Shvarts O, Leppert JT, Pantuck AJ, Figlin RA, Belldegrun AS.
    J Urol; 2005 Aug 15; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
    [Abstract] [Full Text] [Related]

  • 18. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
    Klatte T, Patard JJ, de Martino M, Bensalah K, Verhoest G, de la Taille A, Abbou CC, Allhoff EP, Carrieri G, Riggs SB, Kabbinavar FF, Belldegrun AS, Pantuck AJ.
    J Urol; 2008 May 15; 179(5):1719-26. PubMed ID: 18343437
    [Abstract] [Full Text] [Related]

  • 19. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R, Hutterer G, Chromecki T, Imamovic A, Kampel-Kettner K, Rehak P, Langner C, Pummer K.
    Eur Urol; 2010 Jan 15; 57(1):102-9. PubMed ID: 19062157
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C, Song C, Hong JH, Kim CS, Ahn H.
    J Urol; 2008 Aug 15; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.